Accuracy of three screening tools for prenatal substance use

Obstetrics and Gynecology

Volumn 133, Issue 5, 2019, Pages 952-961

  Coleman Cowger, Victoria H ^a   Oga, Emmanuel A ^a   Peters, Erica N ^a   Trocin, Kathleen E ^a   Koszowski, Bartosz ^a   Mark, Katrina ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; BENZODIAZEPINE DERIVATIVE; CANNABIS; COCAINE; ILLICIT DRUG; OPIATE; TRICYCLIC ANTIDEPRESSANT AGENT;

4PS PLUS; ADULT; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; FEMALE; HAIR ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MODIFIED ALCOHOL SMOKING AND SUBSTANCE INVOLVEMENT SCREENING TEST; NIDA QUICK SCREEN ASSIST; PREDICTIVE VALUE; PREGNANT WOMAN; PRENATAL SCREENING; PRESCRIPTION DRUG MISUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SUBSTANCE USE; SUBSTANCE USE RISK PROFILE PREGNANCY; TEST RETEST RELIABILITY; URINALYSIS; DRUG DEPENDENCE; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL DIAGNOSIS; QUESTIONNAIRE; REPRODUCIBILITY; SUBSTANCE ABUSE;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; SURVEYS AND QUESTIONNAIRES;

EID: 85065347624     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000003230     Document Type: Article

References (23)

1. Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2017 national survey on drug use and health (HHS publication no. SMA 18-5068, NSDUH series H-53). Rockville (MD): Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2018.
2. Center for Behavioral Health Statistics and Quality. 2016 National survey on drug use and health public use file codebook. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2017.
3. Substance Abuse and Mental Health Services Administration. The NSDUH report: substance use among women during pregnancy and following childbirth. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2009.
4. World Health Organization. Guidelines for the identification and management of substance use and substance use disorders in pregnancy. Geneva (Switzerland): World Health Organization; 2014.
5. Opioid use and opioid use disorder in pregnancy. Committee Opinion No. 711. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;130:e81-94.
6. Wright TE, Terplan M, Ondersma SJ, Boyce C, Yonkers K, Chang G, et al. The role of screening, brief intervention, and referral to treatment in the perinatal period. Am J Obstetrics Gynecol 2016;215:539-47.
7. Perreira KM, Cortes KE. Race/ethnicity and nativity differences in alcohol and tobacco use during pregnancy. Am J Public Health 2006;96:1629-36.
8. Chasnoff I, Wells A, McGourty R, Bailey L. Validation of the 4P's Plus screen for substance use in pregnancy validation of the 4P's Plus. J Perinatology 2007;27:744-8.
9. National Institute on Drug Abuse. Resource guide: screening for drug use in general medical settings. Available at: https:// www.drugabuse.gov/publications/resource-guide-screeningdrug-use-in-general-medical-settings. Retrieved August 7, 2018.
10. Yonkers KA, Gotman N, Kershaw T, Forray A, Howell HB, Rounsaville BJ. Screening for prenatal substance use: development of the substance use risk profile-pregnancy scale. Obstetrics Gynecol 2010;116:827-33.
11. U.S. Preventive Services Task Force. Final update summary: drug use, illicit: screening.Available at: https://www.uspreventiveservicestaskforce. org/Page/Document/UpdateSummaryFinal/ drug-use-illicit-screening. Retrieved June 20, 2018.
12. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ 2015; 351:h5527.
13. Coleman-Cowger VH, Oga EA, Peters EN, Trocin K, Koszowski B, Mark K. Comparison and validation of screening tools for substance use in pregnancy: a cross-sectional study conducted in Maryland prenatal clinics. BMJ Open 2018;8: e020248.
14. DuPont RL, Baumgartner WA. Drug testing by urine and hair analysis: complementary features and scientific issues. Forensic Sci Int 1995;70:63-76.
15. Ledgerwood DM, Goldberger BA, Risk NK, Lewis CE, Price RK. Comparison between self-report and hair analysis of illicit drug use in a community sample of middle-aged men. Addict behaviors 2008;33:1131-9.
16. Maxim LD, Niebo R, Utell MJ. Screening tests: a review with examples. Inhalation Toxicol 2014;26:811-28.
17. Terplan M, Kennedy-Hendricks A, Chisolm MS. Article commentary: prenatal substance use: exploring assumptions of maternal unfitness. Substance abuse: research and treatment. Subst Abuse 2015;9:1-4.
18. Saitman A, Park HD, Fitzgerald RL. False-positive interferences of common urine drug screen immunoassays: a review. J Anal Toxicol 2014;38:387-96.
19. Roberts SC, Nuru-Jeter A. Women's perspectives on screening for alcohol and drug use in prenatal care. Women's Health Issues 2010;20:193-200.
20. Marx RG, Menezes A, Horovitz L, Jones EC, Warren RF. A comparison of two time intervals for test-retest reliability of health status instruments. J Clin Epidemiol 2003;56:730-5.
21. Kotelchuck M, Cheng ER, Belanoff C, Cabral HJ, Babakhanlou-Chase H, Derrington TM, et al. The prevalence and impact of substance use disorder and treatment on maternal obstetric experiences and birth outcomes among singleton deliveries in Massachusetts. Matern Child Health J 2017;21:893-902.
22. Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva (Switzerland): World Health Organization; 1968.
23. Christmas JT, Knisely JS, Dawson KS, Dinsmoor MJ, Weber SE, Schnoll SH. Comparison of questionnaire screening and urine toxicology for detection of pregnancy complicated by substance use. Obstetrics Gynecol 1992;80:750-4.